risperidone has been researched along with Dissociative Identity Disorder in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Dissociative Identity Disorder: A dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behavior patterns and social friendships. Transition from one personality to another is sudden.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Urbina, TM | 1 |
May, T | 1 |
Hastings, M | 1 |
Lai, CH | 1 |
2 other studies available for risperidone and Dissociative Identity Disorder
Article | Year |
---|---|
Navigating Undiagnosed Dissociative Identity Disorder in the Inpatient Setting: A Case Report.
Topics: Adaptation, Psychological; Adult; Antidepressive Agents; Antipsychotic Agents; Cognitive Behavioral | 2017 |
Dissociative identity disorder may be relieved by the combined treatments of mirtazapine and risperidone: case report of an adolescent.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Dissociative Identity Disorder; | 2012 |